R01 GM051405/GM/NIGMS NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1996	1
1999	1
2002	1
2004	3
2005	2
2008	2
2009	1
2010	3
2011	4
2012	2
2013	6
2014	7
2015	3
2016	2
2017	3
2018	3
2019	2
2020	4
2021	2
2022	6
2023	2
2024	0

1

Li J, Kim SG, Blenis J. Li J, et al. Cell Metab. 2014 Mar 4;19(3):373-9. doi: 10.1016/j.cmet.2014.01.001. Epub 2014 Feb 6. Cell Metab. 2014. PMID: 24508508 Free PMC article. Review.

2

The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation.

Mendoza MC, Er EE, Blenis J. Mendoza MC, et al. Trends Biochem Sci. 2011 Jun;36(6):320-8. doi: 10.1016/j.tibs.2011.03.006. Epub 2011 Apr 30. Trends Biochem Sci. 2011. PMID: 21531565 Free PMC article. Review.

3

Tumor-produced and aging-associated oncometabolite methylmalonic acid promotes cancer-associated fibroblast activation to drive metastatic progression.

Li Z, Low V, Luga V, Sun J, Earlie E, Parang B, Shobana Ganesh K, Cho S, Endress J, Schild T, Hu M, Lyden D, Jin W, Guo C, Dephoure N, Cantley LC, Laughney AM, Blenis J. Li Z, et al. Nat Commun. 2022 Oct 20;13(1):6239. doi: 10.1038/s41467-022-33862-0. Nat Commun. 2022. PMID: 36266345 Free PMC article.

4

FAM120A couples SREBP-dependent transcription and splicing of lipogenesis enzymes downstream of mTORC1.

Cho S, Chun Y, He L, Ramirez CB, Ganesh KS, Jeong K, Song J, Cheong JG, Li Z, Choi J, Kim J, Koundouros N, Ding F, Dephoure N, Jang C, Blenis J, Lee G. Cho S, et al. Mol Cell. 2023 Aug 17;83(16):3010-3026.e8. doi: 10.1016/j.molcel.2023.07.017. Mol Cell. 2023. PMID: 37595559

5

Balancing lysosome abundance in health and disease.

Mutvei AP, Nagiec MJ, Blenis J. Mutvei AP, et al. Nat Cell Biol. 2023 Sep;25(9):1254-1264. doi: 10.1038/s41556-023-01197-7. Epub 2023 Aug 14. Nat Cell Biol. 2023. PMID: 37580388 Review.

6

Metabolite activation of tumorigenic signaling pathways in the tumor microenvironment.

Low V, Li Z, Blenis J. Low V, et al. Sci Signal. 2022 Nov 8;15(759):eabj4220. doi: 10.1126/scisignal.abj4220. Epub 2022 Nov 8. Sci Signal. 2022. PMID: 36346837 Review.

7

Targeting mTOR in the Context of Diet and Whole-body Metabolism.

Koundouros N, Blenis J. Koundouros N, et al. Endocrinology. 2022 Jun 1;163(6):bqac041. doi: 10.1210/endocr/bqac041. Endocrinology. 2022. PMID: 35366325 Free PMC article. Review.

8

mTORC1 promotes cell growth via m⁶A-dependent mRNA degradation.

Cho S, Lee G, Pickering BF, Jang C, Park JH, He L, Mathur L, Kim SS, Jung S, Tang HW, Monette S, Rabinowitz JD, Perrimon N, Jaffrey SR, Blenis J. Cho S, et al. Mol Cell. 2021 May 20;81(10):2064-2075.e8. doi: 10.1016/j.molcel.2021.03.010. Epub 2021 Mar 22. Mol Cell. 2021. PMID: 33756105 Free PMC article.

9

Suppression of nuclear GSK3 signaling promotes serine/one-carbon metabolism and confers metabolic vulnerability in lung cancer cells.

He L, Endress J, Cho S, Li Z, Zheng Y, Asara JM, Blenis J. He L, et al. Sci Adv. 2022 May 20;8(20):eabm8786. doi: 10.1126/sciadv.abm8786. Epub 2022 May 20. Sci Adv. 2022. PMID: 35594343 Free PMC article.

10

Nutrient regulation of the mTOR complex 1 signaling pathway.

Kim SG, Buel GR, Blenis J. Kim SG, et al. Mol Cells. 2013 Jun;35(6):463-73. doi: 10.1007/s10059-013-0138-2. Epub 2013 May 20. Mol Cells. 2013. PMID: 23694989 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

58 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year